HPV Vaccine Generally Well Tolerated in Males
WEDNESDAY, Nov. 4, 2020 -- Human papillomavirus (HPV) vaccines are safe and well tolerated in males, with few reports of adverse events, according to a study published online Nov. 3 in the British Journal of Clinical Pharmacology.
Giulia Bonaldo,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 4, 2020 Category: Pharmaceuticals Source Type: news
HPV Vaccination Remains Below Healthy People Goals HPV Vaccination Remains Below Healthy People Goals
Rates of human papillomavirus vaccination increased for both boys and girls in the United States over the past decade but remain below target levels and vary widely among states.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - October 14, 2020 Category: Infectious Diseases Tags: Pediatrics News Source Type: news
Quality Improvement Coaching for Human Papillomavirus Vaccination Coverage: A Process Evaluation in 3 States, 2018-2019
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - October 8, 2020 Category: International Medicine & Public Health Tags: Public Health Source Type: news
Impact of HPV vaccination mandates on social inequalities
(University of California - Riverside) A postdoctoral researcher at the University of California, Riverside, has discovered Human papillomavirus, or HPV, vaccination mandates fall short of ensuring both higher levels of uptake and equal uptake of the vaccine across socioeconomic and racial-ethnic groups. The findings could help facilitate equal access to and compliance with uptake of COVID-19 vaccines, once they are available. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 5, 2020 Category: Infectious Diseases Source Type: news
HPV Vaccination Tied to Decrease in Invasive Cervical Cancer Risk
THURSDAY, Oct. 1, 2020 -- Quadrivalent human papillomavirus (HPV) vaccination of girls and women aged 10 to 30 years is associated with a reduced risk for invasive cervical cancer, according to a study published in the Oct. 1 issue of the New... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 1, 2020 Category: Pharmaceuticals Source Type: news
HPV Vaccine Proves Its Mettle Against Cervical Cancer
WEDNESDAY, Sept. 30, 2020 -- Girls who are vaccinated against human papillomavirus (HPV) may drastically cut their chances of developing cervical cancer by age 30, a huge, new study finds.
Researchers found that of more than 1.6 million young... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 30, 2020 Category: General Medicine Source Type: news
A Cross-Sectional Survey to Evaluate Potential for Partnering With School Nurses to Promote Human Papillomavirus Vaccination
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - September 24, 2020 Category: International Medicine & Public Health Tags: Public Health Source Type: news
Cancers Associated with Human Papillomavirus in American Indian and Alaska Native Populations - United States, 2013-2017
This report describes incidence of human papillomavirus--associated cancers in American Indian and Alaska Native populations in the United States during 2013-2017. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 17, 2020 Category: American Health Tags: American Indian - Alaska Native Health Cancer HPV Infection (Human Papillomavirus) MMWR Morbidity & Mortality Weekly Report Source Type: news
Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
Basel, 16 September 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec®PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information from this test supports clinical decisions about which women will benefit most from immediate follow-up. Laboratories can now use CINtecPLUS Cytology to triage positive results from the cobas ® HPV Test run on the fully integrated, automated and high-throughput co...
Source: Roche Media News - September 16, 2020 Category: Pharmaceuticals Source Type: news
Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
Basel, 16 September 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec®PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information from this test supports clinical decisions about which women will benefit most from immediate follow-up. Laboratories can now use CINtecPLUS Cytology to triage positive results from the cobas ® HPV Test run on the fully integrated, automated and high-throughput co...
Source: Roche Investor Update - September 16, 2020 Category: Pharmaceuticals Source Type: news
HPV Vaccination Rates Increasing Among 15-Year-Olds
MONDAY, Sept. 14, 2020 -- From 2011 to 2017, there was an increase in the proportion of U.S. 15-year-olds with at least one-dose or two-dose human papillomavirus (HPV) vaccination, according to a study published online Sept. 14 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 14, 2020 Category: Pharmaceuticals Source Type: news
HPV Vaccination Rises Among U.S. Kids, But Many Still Unprotected
MONDAY, Sept. 14, 2020 -- More U.S. kids are getting a recommended vaccine that protects against several cancers -- but there is still much room for improvement, a new study finds.
At issue is the vaccine against human papillomavirus (HPV). Certain... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 14, 2020 Category: General Medicine Source Type: news
Sexually transmitted infections and screening for chlamydia in England, 2019, PHE
Report notes increase in diagnoses of sexually transmitted infections (n=468,342, increase 5%), gonorrhoea (n=70,936; 26%), syphilis (n=7,982; 10%), and Mycoplasma genitalium (5,311; 196%) since 2018, but decreases in first episode genital warts in 15 to 17 year olds. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 4, 2020 Category: Consumer Health News Source Type: news
Genetic and Spatial Heterogeneity in Human Papillomavirus-Associated Oropharyngeal Cancer
Joseph Powell will discuss how heterogeneous subpopulations of HPV+ head and neck cancer cells drive unique disease states, cell-cell interactions, and microenvironment dynamics, and have... (Source: The Scientist)
Source: The Scientist - August 20, 2020 Category: Science Tags: Sponsored Webinars Source Type: news
Topically Applied Treatments for External Genital Warts Topically Applied Treatments for External Genital Warts
This study used a network meta-analysis to compare their efficacy and safety.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 14, 2020 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
